OSE Pharma SA (OSE) — Working Capital to Net Assets Ratio
OSE Pharma SA (OSE) has a Working Capital to Net Assets ratio of 71.6% as of June 2025. Working capital of €36.23 Million (current assets of €55.63 Million minus current liabilities of €19.40 Million) is measured against net assets of €50.60 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See OSE Pharma SA defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
OSE Pharma SA Working Capital to Net Assets (2012–2024)
This chart shows how OSE Pharma SA's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of June 2025, the ratio stands at 71.6%, reflecting working capital of €36.23 Million against net assets of €50.60 Million EUR. For the complete balance sheet picture, see OSE current and non-current assets.
Annual Working Capital to Net Assets for OSE Pharma SA (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for OSE Pharma SA from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check OSE financial resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 77.9% | €49.71 Million | €63.81 Million | €69.93 Million | €20.22 Million | ▲ +27.1 pp |
| 2023 | 50.8% | €11.68 Million | €22.98 Million | €30.48 Million | €18.80 Million | ▼ -13.5 pp |
| 2022 | 64.3% | €20.93 Million | €32.55 Million | €37.20 Million | €16.27 Million | ▲ +6.6 pp |
| 2021 | 57.7% | €27.44 Million | €47.53 Million | €44.21 Million | €16.76 Million | ▲ +15.8 pp |
| 2020 | 42.0% | €25.70 Million | €61.24 Million | €39.83 Million | €14.13 Million | ▲ +9.9 pp |
| 2019 | 32.0% | €18.73 Million | €58.49 Million | €33.06 Million | €14.33 Million | ▲ +9.4 pp |
| 2018 | 22.6% | €13.95 Million | €61.75 Million | €23.02 Million | €9.07 Million | ▲ +5.5 pp |
| 2017 | 17.1% | €9.49 Million | €55.45 Million | €23.99 Million | €14.50 Million | ▼ -10.6 pp |
| 2016 | 27.7% | €17.88 Million | €64.53 Million | €36.54 Million | €18.66 Million | ▼ -73.0 pp |
| 2015 | 100.7% | €14.57 Million | €14.48 Million | €16.88 Million | €2.31 Million | ▲ +105.4 pp |
| 2014 | -4.7% | €38.00K | €-803.00K | €1.93 Million | €1.89 Million | ▲ +24.8 pp |
| 2013 | -29.5% | €255.00K | €-864.00K | €308.00K | €53.00K | ▼ -2.7 pp |
| 2012 | -26.9% | €170.00K | €-633.00K | €254.00K | €84.00K | — |